Early administration of levosimendan is associated with improved kidney function after cardiac surgery - a retrospective analysis.

J Cardiothorac Surg 2014 Nov 18;9:167. Epub 2014 Nov 18.

Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany.

Background: Several animal studies suggest beneficial effects on kidney function upon administration of levosimendan. As recent data from clinical studies are heterogeneous, we sought to investigate whether levosimendan is associated with improved postoperative kidney function in cardiac surgery patients with respect to timing of its administration.

Methods: Retrospective, single centre, observational analysis at a university hospital in Berlin, Germany. All adult patients without preoperative renal dysfunction that underwent coronary artery bypass grafting and/or valve reconstruction/replacement between 01/01/2007 and 31/12/2011 were considered for analyses.

Results: Out of 1.095 included patients, 46 patients were treated with levosimendan due to a severely reduced left ventricular systolic function preoperatively (LVEF < 35%) and/or clinical signs of a low cardiac output syndrome. Sixty-one percent received the drug whilst in the OR, 39% after postoperative intensive care unit admission. When levosimendan was given immediately after anaesthesia induction, creatinine plasma levels (p = 0.009 for nonparametric analysis of longitudinal data in a two-factorial design) and incidence of postoperative renal dysfunction (67.9% vs. 94.4%; p = 0.033) were significantly reduced in contrast to a later start of treatment. In addition, duration of renal replacement therapy was significantly shorter (79 [35;332] vs. 272 [132;703] minutes; p = 0.046) in that group.

Conclusions: Postoperative kidney dysfunction is a common condition in patients under going cardiac surgery. Patients with severely reduced left ventricular function and/or clinical signs of a low cardiac output syndrome who preoperatively presented with a normal kidney function may benefit from an early start of levosimendan administration, i.e. immediately after anaesthesia.

Trial Registration: Clinicaltrials.gov-ID: NCT01918618 .

Download full-text PDF

Source
http://cardiothoracicsurgery.biomedcentral.com/articles/10.1
Publisher Site
http://dx.doi.org/10.1186/s13019-014-0167-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240807PMC
November 2014
39 Reads

Publication Analysis

Top Keywords

kidney function
12
function cardiac
8
cardiac surgery
8
levosimendan associated
8
associated improved
8
administration levosimendan
8
single centre
4
university hospital
4
treated levosimendan
4
included patients
4
patients treated
4
analysis university
4
retrospective single
4
observational analysis
4
centre observational
4
patients patients
4
timing administrationmethods
4
surgery patients
4
patients
4
valve reconstruction/replacement
4

References

(Supplied by CrossRef)

MM O'Brien et al.
Med Care 2004

JW Sear et al.
Br J Anaesth 2005

WG Toller et al.
Anesthesiology 2006

DP Figgitt et al.
Drugs 2001

JGF Cleland et al.
Curr Opin Cardiol 2002

JR Kersten et al.
Anesth Analg 2000

PF Soeding et al.
Eur J Pharmacol 2011

M Carl et al.
Ger Med Sci 2010

JJV McMurray et al.
Eur J Heart Fail 2012

N Yakut et al.
Interact Cardiovasc Thorac Surg 2008

E Grossini et al.
J Pharmacol Exp Ther 2012

Similar Publications